These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24694834)

  • 1. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
    Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
    Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
    Zhao B; Zhao H; Zhao N; Zhu XG
    J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of liver cancer in mice by the intratumoral injection of an octreotide-based temperature‑sensitive gel.
    Zhang L; Yu S; Duan Z; Wang Q; Tian G; Tian Y; Zhao W; Wang H; Zhang C; Guo S; Liu Q; He G; Bian T; Chang J; Jin X; Cui D
    Int J Mol Med; 2014 Jan; 33(1):117-27. PubMed ID: 24173662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
    Wang CH; Tang CW
    Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
    Hubina E; Nanzer AM; Hanson MR; Ciccarelli E; Losa M; Gaia D; Papotti M; Terreni MR; Khalaf S; Jordan S; Czirják S; Hanzély Z; Nagy GM; Góth MI; Grossman AB; Korbonits M
    Eur J Endocrinol; 2006 Aug; 155(2):371-9. PubMed ID: 16868153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
    Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
    Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors.
    Oda Y; Tanaka Y; Naruse T; Sasanabe R; Tsubamoto M; Funahashi H
    Surg Today; 2002; 32(8):690-4. PubMed ID: 12181718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model.
    Dalezis P; Geromichalos GD; Trafalis DT; Pissimissis N; Panagiotopoulou D; Galaktidou G; Papageorgiou E; Papageorgiou A; Daifoti Z; Lymperi M; Koutsilieris M
    In Vivo; 2012; 26(1):75-86. PubMed ID: 22210719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 stimulates type 3 iodothyronine deiodinase expression in a mouse insulinoma cell line.
    Akiyama S; Ogiwara T; Aoki T; Tsunekawa K; Araki O; Murakami M
    Life Sci; 2014 Oct; 115(1-2):22-8. PubMed ID: 25241124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide.
    Fisher WE; Muscarella P; O'Dorisio TM; O'Dorisio MS; Kim JA; Doran TA; Sabourin CL; Schirmer WJ
    Surgery; 1996 Aug; 120(2):234-40; discussion 240-1. PubMed ID: 8751588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
    Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
    J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.
    Hashimoto K; Masumori N; Tanaka T; Maeda T; Kobayashi K; Kitamura H; Hirata K; Tsukamoto T
    Prostate; 2013 Apr; 73(5):500-11. PubMed ID: 22996996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel molecular aspects of pituitary adenomas.
    Hubina E; Ruscica M; Nanzer AM; Czirják S; Góth MI; Grossman AB; Korbonits M
    J Endocrinol Invest; 2005; 28(11 Suppl International):87-92. PubMed ID: 16625855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT1 requirement for PKR-induced cell cycle arrest in vascular smooth muscle cells in response to heparin.
    Handy I; Patel RC
    Gene; 2013 Jul; 524(1):15-21. PubMed ID: 23597922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
    Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
    Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
    Chiang KC; Yeh CN; Pang JH; Hsu JT; Yeh TS; Chen LW; Kuo SF; Hsieh PJ; Pan YC; Takano M; Chen TC; Feng TH; Kittaka A; Juang HH
    Anticancer Res; 2016 Jul; 36(7):3307-13. PubMed ID: 27354587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.